Chlorhexidine Coverage for Newborn Umbilical Cord Care in Bangladesh and Nepal

Chlorhexidine Coverage for Newborn Umbilical Cord Care in Bangladesh and Nepal
Citation: Singh, K., Simmons, E., Garriga, B., Hoover, G., Ijdi, R.E., & Ashish, K.C. (2024). Policy Brief: National Chlorhexidine Coverage and Predictors for Newborn Umbilical Cord Care in Bangladesh and Nepal. Chapel Hill, NC, USA: Data for Impact.
Abstract: This policy brief summarizes findings from a paper by Singh et al. (2024), which looked at coverage and factors associated with receipt of chlorhexidine for newborn umbilical cord care in Bangladesh and Nepal.

Reducing neonatal mortality is a pressing global health issue. In 2022, it was estimated that there were 2.3 million deaths among children under one month old. Infection is among the leading causes of neonatal mortality, including omphalitis, which is an infection of the umbilical cord. Hygienic cord care is an important means of preventing newborn infections and death. In 2022, the World Health Organization (WHO) recommended chlorhexidine for newborn umbilical cord care for the first week of life in settings where potentially harmful substances are often applied.
Shortname: FS-24-702
Author(s): Singh, K., Simmons, E., Garriga, B., Hoover, G., Ijdi, R.E., & Ashish, K.C.
Year: 2024
Language: English
Region(s): BANGLADESH, NEPAL